-- 
Delhaize, Dexia, Omega Pharma, Vastned: Benelux Equity Preview

-- B y   J o h n   M a r t e n s
-- 
2011-08-05T04:00:05Z

-- http://www.bloomberg.com/news/2011-08-05/delhaize-dexia-omega-pharma-vastned-benelux-equity-preview.html
The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  The  AEX-Index (AEX)  in Amsterdam declined 3.2 percent to 300.85.
 Belgium ’s Bel20 Index sank 2.9 percent to 2,223.67. Luxembourg’s
LuxX Index tumbled 3.6 percent to 1,232.67.  Dutch stocks:  Vastned Offices/Industrial NV (VNOI NA): The property fund
that plans to merge with Nieuwe Steen Investments NV said its
first-half direct investment result fell to 10.1 million euros
($14.3 million) from 13.1 million euros a year earlier. The
shares lost 3.4 percent to 9.50 euros.  Vastned Retail NV (VASTN)  : The Dutch owner of shopping
centers in the Netherlands,  Spain ,  France  and Belgium said its
first-half direct investment result was unchanged at 33.6
million euros. The shares fell 4.3 percent to 42.90 euros.  Belgian stocks:  Delhaize Group SA (DELB)  : The owner of the Food Lion
supermarkets in the U.S. may say second-quarter net income rose
to 118.8 million euros, according to the average of six analyst
estimates compiled by Bloomberg, from 114 million euros a year
earlier. Delhaize retreated 0.3 percent to 47.03 euros.  Dexia SA (DEXB)  : Belgium’s largest bank by assets
reported a record quarterly net loss of 4.03 billion euros,
which included a 377 million-euro pretax writedown of Greek debt
holdings, and said central-bank funding increased to about 34
billion euros at the end of June. Dexia decreased 1.5 percent to
1.66 euros.  Omega Pharma NV (OME BB): Belgium’s biggest supplier of
pharmacy products reported first-half earnings excluding some
items rose to 1.45 euros a share from 1.44 euros a year earlier.
Earnings missed the 1.52 euro-a-share median estimate of five
analysts surveyed by Bloomberg News.  Omega Pharma (OME)  dropped 2.6
percent to 30.77 euros.  To contact the reporter on this story:
John Martens in Brussels at 
 jmartens1@bloomberg.net   To contact the editor responsible for this story:
Angela Cullen at   acullen8@bloomberg.net  